Director, Medical Evidence Generation Asset Lead (Other Solid Tumor)
Director, Medical Evidence Generation Asset Lead (Other Solid Tumor)
Employer Active
Job Alert
You will be updated with latest job alerts via email
Share
Job Alert
You will be updated with latest job alerts via email
$ 169700 - 282900
1 Vacancy
Job Description
Role Summary
The Director Medical Evidence Generation Asset Lead (Other Solid Tumor) within the Chief Medical Office organization will serve as a single point of contact between the Oncology Medical Affairs Asset Lead CMO functional lines and other internal stakeholders to ensure that the medical evidence generation needs of the asset are defined and delivered.
Key Responsibilities
Medical Evidence Generation Strategy & Planning
- Accountable for partnering with Oncology Medical Affairs Asset(s) Lead to develop and deliver the integrated evidence generation plan (IEP) for 1 or more oncology assets
- Acts as single point of contact for Medical Affairs team(s) providing guidance and input on the various research approaches available within the organization
- Orchestrate a multidisciplinary approach to bridge evidence gaps leveraging capabilities and expertise across epidemiological RWE external patientcentered research
- Leads a crossfunctional team of colleagues responsible for developing and executing the asset(s) IEP ensuring appropriate representation from both a functional line and geographical perspective
- Engage with all relevant stakeholders (e.g. Medical Affairs Epidemiology/RWE Statistics/Programming Regulatory Safety Operations Quality Global Access & Value International etc.) to ensure comprehensive evidence generation planning is conducted and all tactics are implemented in support of medical strategy
- Guide teams to ensure consistency of approach appropriate planning and oversight of all evidence generation activities for assigned assets
- Provide expert input into evidence generation tactical implementation plans throughout the asset lifecycle
- Represent Medical Evidence Generation (MEG) group as Core member of Global Medical Asset Team(s)
- Chair or cochair Evidence Generation Subcommittees for 1 or more oncology assets ensuring appropriate strategic and technical review occur for all evidence generation tactics
- Ensure adequate MEG representation for relevant planning and operational review committees (e.g. Program Team Scientific Publications etc.)
- Engage Integrated Evidence Planning Success Team to conduct review/refresh of asset(s) IEPs on a regular basis throughout the asset lifecycle responding to both internal and external environments
- Acts as a champion for identifying and implementing novel approaches to realworld evidence generation activities
Medical Evidence Generation IEP Delivery / Tactical Implementation
- Oversee the overall execution of the IEP evidence generation activities of assigned asset(s)
- Engage MEG Program Management team to coordinate ongoing oversight and tracking of evidence generation activities to ensure timely and quality execution of the medical affairs research agenda
- Partner with MEG and Medical Enablement & Quality team to report on study progress and metrics to R&D Medical Affairs leadership and other key stakeholders
- Provide input to partner lines on study design and planning to ensure evidence generation activities are feasible and adequately resourced
- Lead and/or participate in early research concept discussions with internal and external stakeholders as the primary representative from the MEG organization
- Proactively and continuously aim to identify and mitigate medical affairs researchrelated risks and limitations
- Partner with relevant partner lines to find innovative efficient and timely approaches to achieve Medical Affairs research agenda deliverables
- Act as MEG asset reviewer for critical regulatory and select studylevel documents as needed
- Represent asset(s) in enterprise and/or therapeutic area evidence generation initiatives
Stakeholder Management
- Responsible for developing and maintaining strong relationships with internal functional line leaders in R&D Medical and Commercial (as appropriate) organizations
- Serve as point of contact for medical evidence generation activities for external stakeholders including key opinion leaders external researchers regulatory agencies (as appropriate)
- Engage Chief Medical Office R&D Medical Affairs Global Access & Value etc. partner lines regarding strategic issues project plans options and recommendations to support efficient and highquality evidence generation
- Establish and maintain effective communication between global regional and countrylevel medical affairs colleagues
Qualifications
- Medical degree with 4 years of experience PharmD PhD or equivalent with 5 years of experience MS MPH or MBA with 7 years of experience or BS with 8 years of experience in a life science discipline.
- Extensive experience in Oncology epidemiologic and/or infectious diseases research required
- Experience in Oncology clinical development microbiology and clinical epidemiology preferred
- Expert knowledge of drug/oncology development process
- Demonstrated ability to advise on medical evidence generation strategies
- Experience leading & growing crossfunctional teams strong influence/matrix leadership skills
- Experience across various research methodologies using realworld evidence observational and lowinterventional study designs
- Highly effective verbal and written communication skills with respect to evidence generation planning and decision making
- Strong organizational and project management skills
- Experience engaging with and supporting regulatorygrade realworld evidence projects including contributing to regulatory interactions/correspondences
Candidate must demonstrate a breadth of diverse leadership experiences and capabilities including: the ability to influence and collaborate with peers develop and coach others oversee and guide the work of other colleagues to achieve meaningful outcomes and create business impact.
NONSTANDARD WORK SCHEDULE TRAVEL OR ENVIRONMENT REQUIREMENTS
Position requires up to 15% travel including domestic and global travel and flexibility to work across various time zones when necessary.
Work Location Assignment:Hybrid/On Premise
Relocation assistance may be available based on business needs and/or eligibility.
Sunshine Act
Pfizer reports payments and other transfers of value to health care providers as required by federal and state transparency laws and implementing regulations. These laws and regulations require Pfizer to provide government agencies with information such as a health care providers name address and the type of payments or other value received generally for public disclosure. Subject to further legal review and statutory or regulatory clarification which Pfizer intends to pursue reimbursement of recruiting expenses for licensed physicians may constitute a reportable transfer of value under the federal transparency law commonly known as the Sunshine Act. Therefore if you are a licensed physician who incurs recruiting expenses as a result of interviewing with Pfizer that we pay or reimburse your name address and the amount of payments made currently will be reported to the government. If you have questions regarding this matter please do not hesitate to contact your Talent Acquisition representative.
EEO & Employment Eligibility
Pfizer is committed to equal opportunity in the terms and conditions of employment for all employees and job applicants without regard to race color religion sex sexual orientation age gender identity or gender expression national origin disability or veteran status. Pfizer also complies with all applicable national state and local laws governing nondiscrimination in employment as well as work authorization and employment eligibility verification requirements of the Immigration and Nationality Act and IRCA. Pfizer is an EVerify employer. This position requires permanent work authorization in the United States.
Required Experience:
Director
Employment Type
Full-Time
